METHODS
A pilot study was conducted in a small group of participants (n = 10) with SCD who were asked to use a smartphone and answer questions on the e-Diary as presented on precompleted paper-based measures. A second pilot study was conducted in a small group of participants (n = 21) with SCD who did not participate in the first pilot study and were asked to use a smartphone to answer questions on the e-Diary about the pain and symptoms they experienced over the previous 12 hours. The Institutional
Sample and Setting
Participants were children and adolescents with SCD who were recruited from the Sickle Cell Disease Foundation of California (SCDFC). The SCDFC is a nonprofit community-based organization involved in programs such as (1) LifeSteps/Youth Program, which targets adolescents and young adults with SCD, aged 13 to 25 years and provides educational workshops and social service activities; (2) Together We Can! Learning Center, which offers one-onone academic support services on Saturdays to school-aged children; and (3) Camp Crescent Moon, a medical camp for children with sickle cell disease (SCD) aged 8 to 14 years. SCDFC serves the sickle cell community residing in the greater Los Angeles area. In 2006, the SCDFC expanded and opened a satellite office in the Inland Empire (San Bernardino and Riverside Counties) approximately 75 miles from Los Angeles to address the lack of services available for individuals with SCD. The SCDFC offers services to an estimated 5000 individuals throughout the state of California. The ethnic mix of the population served is approximately 90% African-Americans. The others (10%) are Hispanics and other origins.
Eligibility
Children and adolescents were eligible to participate if: (1) they were 10 to 17 years of age; (2) diagnosed with SCD; and (3) able to speak, read, write, and understand English. They were excluded if they had major cognitive or neurological impairments (as reported by parents) that may have impacted their ability to understand and use the web-based e-Diary that is accessed by a smartphone. Eligible participants received flyers and were invited by the special projects coordinator from the SCDFC to participate in the study.
Development and Testing of the Web-based e-Diary
One of the coauthors (A.G.) from the computer science department of the UCLA developed a customized web-based e-Diary that included items from well-validated paper-based measures [20] [21] [22] [23] [24] of pain and symptoms that were previously used by children and adolescents with SCD. [25] [26] [27] The web-based e-Diary was designed so that it could be accessed by using the smartphone.
Different from electronic pain diaries that were previously reported in the literature, 6-9 the e-Diary is a webbased application, and not a local application that resides on the smartphone. Even though a local application is faster than a web-based application, it has the disadvantage of being tied to a single wireless handheld device (eg, smartphone), that is, it can work only on the device for which it was developed. We anticipated that technological advances will inevitably occur with wireless handheld devices, and we may want to have the flexibility to use different or more advanced wireless handheld devices. In addition, a web-based application may be accessed, not only by the handheld wireless devices, but also by desktop computers, laptops, netbooks, and other portable electronic devices with wireless connectivity. The speed of wireless connection in the web-based application, when compared to the local application residing on the device was not a problem during the testing. There was greater advantage to having more control and flexibility with the web-based application that would allow changes to occur more readily as technology progresses, thereby increasing the lifetime of the application.
The e-Diary was designed so that when the data were submitted, they were immediately and directly transmitted wirelessly by a service provider to a secured server purchased specifically for the study where it was safely stored in a database. Data stored on the server were immediately downloaded to Excel spreadsheets so that they could be imported into a statistical software program for analyses. This aspect of the web-based e-Diary minimized time delay and errors typically encountered during entries of paper diaries. As data were not stored locally in the device, privacy was maintained, and the risk for loss of confidentiality was minimized in the event that the smartphone was lost or stolen. Furthermore, the smartphone could be deactivated remotely if lost or stolen.
Measures on the e-Diary
The items on the e-Diary were taken from measures with well-established reliability and validity and were previously used by children and adolescents with SCD in our previous studies. [25] [26] [27] [28] [29] These measures are described below.
Symptoms
A list of 27 symptoms that were derived from our previous study 26 was presented with 3 to 5 symptoms per screen at a time (Fig. 1A) . Each screen had the following at the top "Check if you had any of the signs and/or symptoms over the last 12 hours." The symptoms included: (1) general symptoms (fever, headache, tiredness/fatigue, dizziness, general weakness); (2) neurological symptoms (one side weaker than the other side, change in level of alertness, change in behavior, more irritable); (3) changes in color (yellowing of the eyes, being pale, changes in skin color); (4) respiratory symptoms (sniffling, coughing, changes in breathing); (5) gastrointestinal symptoms (nausea, vomiting, change in appetite, diarrhea, constipation); (6) genitourinary symptoms (difficulty with passing urine, pain with passing urine, painful erection); (7) musculoskeletal symptoms (swelling of hands/feet, tenderness, stiffness in joints); and (8) pain. 26 
Pain
If pain was checked, the screens that followed assessed the "current," "worst," and "least" pain, using Visual Analog Scales (VAS). The VAS used in this study was a horizontal line anchored by the words "none" on the left side and "worst pain" on the right side. 20 Unlike the traditional paper version, where the VAS is 10 cm (100 mm) in length, the VAS in the e-Diary was not measured with a ruler, but electronically quantified on a 10-unit metric. The 10-unit metric was selected because the 0 to 10 metric was commonly used by clinicians when assessing pain. Von Baeyer and Hicks 30 recommended that all pediatric pain scales have a 10-unit metric so as to decrease confusion from the many differing numerical values. The VAS lines were preceded with the following questions: (1) "What is your level of pain now?"; (2) "What was your highest level of pain in the past 12 hours?"; and (3) "What was your lowest level of pain in the past 12 hours?"
A screen with a body outline diagram modified with permission from the authors of the Adolescent Pediatric Pain Tool (APPT) was included in the subsequent screens to allow marking of areas on the body where pain was felt. [20] [21] [22] [23] [24] The body outline diagram for marking the location of pain was modified in the electronic version to include additional areas not previously demarcated in the original instrument. The list of pain quality descriptors was included in several screens where the participant was asked to "Select all words that describe your pain". [20] [21] [22] [23] [24] The list had 67 words that were previously tested in children to describe pain quality and included sensory, affective, evaluative, and temporal words from the APPT. The words were presented in similar groupings to that in the original APPT, 24 and were presented as 3 to 5 words per screen.
Medications
Several screens were included to assess utilization of medications (Fig. 1B) . One question was "What medications did you take for pain in the last 12 hours?" This question was linked to the medications list typically prescribed for painful episodes in patients with SCD. 25, 31 For each medication selected, the following questions were asked: (1) "How many times was this medication taken in the last 12 hours?"; (2) "What time was this medication last taken?"; and (3) "How much did this medication help?". Responses to the third question included: "don't know" (0); "did not help at all" (1); "helped a little" (2); "helped some" (3); "helped quite a bit" (4); "helped a lot" (23) . The final question asked was: "What other medications did you take in the last 12 hours?" A corresponding text box was provided after the question.
Other Strategies for Pain
A list of nonpharmacological strategies (Fig. 1C) used to relieve pain 32, 33 was included to allow participants to "Check if you did any of the following to help with your pain": The strategies were: (1) Deep breathing; (2) Relaxation exercises; (3) Heat packs; (4) Hot bath/shower; (5) Massage; (6) Imagery; (7) Distraction (TV, Nintendo); (8) Talking with friends/parents; or (9) None of the above. For each strategy selected, the following questions were asked: (1) "How many times was this activity done in the last 12 hours?"; (2) "What time was this activity last done?"; and (3) "How much did this activity help?". Responses to the third question were: "don't know" (0); "did not help at all" (1); "helped a little" (2); "helped some" (3); "helped quite a bit" (4); "helped a lot." 27 The final question was: "What other activities did you do in the last 12 hours to help with pain?" A corresponding text box was provided after the question.
Sleep
Sleep (Fig. 1C) was assessed with the question, "How much sleep did you have during the night?". 34 This question was followed by these responses: (0) "did not sleep at all (0 h)"; (1) "slept a little ( < 3 h)"; (2) "slept some (3 to 5 h)"; (3) "slept quite a bit (5 to 8 h)"; and (4) "slept a lot (> 8 h)."
Thoughts/Feelings
A checklist (Fig. 1C ) that included words to describe thoughts and feelings 35 
Fluids
The amount of fluids taken was assessed with the question, "How much did you drink in the last 12 hours?" The responses included the size of cup or glass (4 to 12 oz size), and how many servings of that cup or glass were taken. An internal calculator showed the total amount taken in ounces (Fig. 1C) .
Health Care Use
Two items were included to assess utilization of health care services. The first question was, "In the last 12 hours, did you go to: (1) Sickle Cell Clinic; (2) Medical Office; (3) Urgent Care Clinic; (4) Other Clinic; (5) ED; (6) Day Hospital; or (7) None of the above?" The second question was "In the last 12 hours, have you been: (1) hospitalized; (2) discharged from the hospital; or (3) none of the above?".
Additional Questions
Two additional screens had questions that asked participants, (1) "Do you have questions?"; and (2) "Do you have other comments?" A corresponding text box was provided after each question.
Pretesting Procedures
An initial pretest occurred in a private and quiet conference room at the UCLA School of Nursing. The purpose of the initial testing was to test the technical features of the smartphone. A 16-year-old adolescent with SCD used the smartphone to enter items from a completed paper version of the study measures to the e-Diary on the smartphone. Technical changes were made to the e-Diary based upon the initial testing to improve appearance of the images on each screen, navigation (layout and tabs for ease of finding information), function (clear/submit, back, cursor movement), clarification of the wording of questions, and deletion/addition of some items.
A second pretest took place in a private and quiet conference room arranged by the Sickle Cell Disease Foundation. The purpose of the second pretest was to refine and further improve the smartphone screens in terms of touch, navigation, user interaction, readability, functionalities, visual appearance, and overall layout. In addition, the data transfer function was also tested to check that data were correctly downloaded to Excel spreadsheets so that they could be imported into a statistical software program for analyses. To accomplish this, 3 participants (10 to 13 y) with SCD were asked to enter answers from the precompleted paper-based measures to the e-Diary. These measures included a predetermined selection of pain and symptoms typically experienced by individuals with SCD if they had (1) upper respiratory infection; (2) acute chest pain; and (3) vasoocclusive pain episode. Changes were made to refine the e-Diary and simplify the procedure for downloading data to Excel spreadsheets. Table 1 provides examples of the changes that were made during the pretesting procedures.
Pilot Study 1
Participants (n = 10) were recruited by the special projects coordinator of the SCDFC and were scheduled during a 1-hour session that occurred on a Saturday morning. The 10 participants were given 3 precompleted paperbased measures representing symptoms and pain typically experienced by individuals with SCD. The purpose of the first pilot study was to validate that: (1) all the technical features of the smartphone were functioning properly; (2) participants were able to accurately use the e-Diary in the same manner that the paper-based measures were used; and (3) all data were correctly downloaded to Excel spreadsheets and imported into a statistical software program for analyses. Participants were given 3 sets of the paper-based measures that had already been filled out with typical pain and symptom information usually experienced by children with SCD with: (1) upper respiratory infection; (2) acute chest pain; and (3) vasoocclusive pain episode. These 3 sets of precompleted paper-based measures were the same ones used during the pretesting procedures described above. The 10 participants provided a total of 30 responses. We hypothesized that responses to the questions would be 100% accurate when participants entered the items from the precompleted paperbased measures to the e-Diary.
Pilot Study 2
Participants (n = 21) in study 2 were recruited by the special projects coordinator of the SCDFC and were scheduled during a 1-hour session that occurred on a Saturday morning. The purpose of the second pilot study was to test if the participants were able to use the e-Diary to describe their own pain and symptoms over the previous 12 hours.
Data Analysis
Data were downloaded to Excel spreadsheets and were retrieved using a statistical software program (SPSS, version 20.0, Chicago, IL). Descriptive statistics (frequency, percentages, means, SDs) were used to describe the pain and symptoms of participants over the previous 12 hours.
RESULTS

Pilot Study 1
Participants (n = 10) in the first pilot study were children and adolescents with SCD recruited from the programs at the SCDFC who had a mean age of 13.1 ± 2.4 years (range, 10 to 17 y; 5 M and 5 F). The median school grade was seventh grade (range 4th to 11th grade). They completed the e-Diary with at least 80% accuracy (Table 2) when compared with the precompleted paper-based measures. Figure 2 presents an example of e-Diary markings on the body outline diagram for location of pain for upper respiratory infection (2a), acute chest pain (2b), and vasoocclusive pain episode (2c). Figure 3 presents an example of the VAS pain markings for current, highest, and lowest intensity ratings for the vasoocclusive pain episode that participants entered from the paper-based measures (Fig. 3A) to the e-Diary (Fig. 3B) . J Participants (n = 21) in the second pilot study were children and adolescents with SCD recruited from the programs at the SCDFC who had a mean age of 13.4 ± 2.4 years (range, 10 to 17 y; 10 M and 11 F). The median school grade was seventh grade (range 5th to 11th grade). The majority of the participants had hemoglobin SS (n = 10; 47.6%). The remainder had hemoglobin SC (n = 6; 28.6%), or other/unknown (n = 5; 23.8%). On average, some reported having no pain crisis (n = 6; 28.6%) during the previous 12 months, and the others have reported at least 1 to 5 crises (n = 7; 33.3%), or >5 crises (n = 8; 38.1%) in the previous 12 months. They reported having history of acute chest syndrome (n = 7; 33.3%), avascular necrosis (n = 7; 33.3%), asthma (n = 5; 23.8%), and splenectomy (n = 4; 19.0%). They were asked to rate their own symptom experiences over the previous 12 hours using the smartphone, to test their ability to use the smartphone, how easy (on a scale of 0 = not useful at all to 5 = very useful) and how much of a bother (on a scale 0 = not a bother at all to 5 = a lot of bother) it would be if they were to answer the questions.
Symptoms Experienced the Previous 12 Hours
The most frequently marked symptoms (Table 2) were (1) 
Pain Experienced the Previous 12 Hours
Few participants indicated having pain (14.3%) and stiffness in joints (19.0%). One reported having a painful erection (4.8%) the previous 12 hours. The mean pain intensity ratings at the time of completion were (2.0 ± 1.7); range from 1 (mild) to 4 (moderate) on 0 to 10 (electronically quantified metric unit with 10 = highest pain score). The medication indicated for pain was ibuprofen (9.5%); no one indicated acetaminophen with codeine or other combination opioids typically prescribed for moderate pain.
Perception of Sleep During the Night
Sleep scores ranged from 0 (did not sleep at all) to 10 (slept a lot; Z8 h). The mean sleep score was 8.1 ± 1.4 on the 0 to 10 scale; range was 5 to 10 h.
Thoughts/Feelings Reported the Previous 12 Hours
The majority of the participants indicated feelings of being happy (71.4%) and/or content (42.9%). Some indicated feeling tired (33.3%) and a few had indicated being anxious (9.5%); angry (9.5%); sad (9.5%); nervous (9.5%); miserable (4.8%); and/or other (14.3%).
The participants took an average of 3.9 ± 1.6 min to complete the e-Diary questions using the smartphone. When asked how useful the e-Diary would be in helping them talk about pain and symptoms with their doctor or nurse, the mean rating was 4.1 ± 1.5 (on a scale of 0 = not useful at all to 5 = very useful), indicating that it was useful. When asked how much of a bother would it be to answer the questions on the e-Diary using the smartphone, the mean rating 0.6 ± 1.1 (on a scale of 0 = not a bother at all to 5 = a lot of bother), indicating that it would not be much of a bother. Change the font for the medication for consistency; use capital letters In the drop-down menu for question asking "What time was this medication last taken?," the minutes selection should be 00-50 in increments of 10 Add a question mark at the end "Do you have any other thoughts or comments?" Change the wording to state "highest pain" instead of "worst pain" and "lowest pain" instead of "least pain." Use bold font for these words Add space between the question and the line with the Visual Analog Scale Appearance Make the body outline diagram larger to occupy screen and eliminate the zoom feature Indicate "front" and "back" on body outline Align the questions consistently Function When "Submit" is pressed, a screen comes up saying "http:// 131.179.136.154 the value is: 4"; this needs to be removed Add a "Clear" button on some screens When "Other" is checked, add "drop-down" menu to allow selection of medication names Add the items for "select words that describe your thought/ feelings over the past 12 h" and the item on "select the words that describe your pain." In the item "Have been to Sickle Cell Clinic, Hospital, ED, etc. in the past 12 hy If "None of the above" is checked, a free text box appears; this should be removed ED indicates emergency department. 
DISCUSSION
We pretested the web-based e-Diary for self-monitoring of pain and symptoms and then pilot tested it in 2 small groups of children and adolescents with SCD. We found that the participants were able to record pain and symptoms on the e-Diary using the smartphone. The smartphone was easy to use and efficient to complete ( < 5 min). Changes and revisions were made after the pretesting that improved the responsiveness of the screens to touch, navigation, functionalities (submit, clear, cursor movement), visual appearance, and layout. Data showed that the participants were able to accurately (80%) enter items from precompleted paper-based measures to the web-based e-Diary accessed by using the smartphone. In items with <100% accuracy, participants may have made their markings based upon their own signs and symptoms in the previous 12 hours, rather than from the paper-based measures. For example, on the screen with "Check if you experienced any of the following signs and/or symptoms over the last 12 hours," they marked negatively based on their own symptoms, rather than the symptom (eg, fever) that was marked on the paper-based measures.
The e-Diary was also used by children and adolescents to describe their own pain and symptoms, sleep, and thoughts and feelings over the previous 12 hours. Data were downloaded immediately to an Excel spreadsheet and imported readily into a statistical software program. The simple download allows immediate analyses of data, which is a major advantage when compared to traditional paperbased measures. Therefore, data may be monitored in real time by clinicians and researchers enhancing the opportunity to detect health problems early. The direct download of data into the analysis program also minimized the errors, personnel cost, and time delay associated with having to enter data from paper-based measures.
The overall pain intensity reported by participants was mild (2.0 on 0 to 10 scale), which was lower than previous reports of overall pain intensity in adult patients (4.5 on 0 to 9 scale) who completed daily diaries at home 36 when they participated in the Pain in Sickle Cell Epidemiology (PiSCES). It is interesting to note that one of the most commonly reported symptoms was feeling tired and, yet the mean sleep score was 8.1 (0 = did not sleep at all to 10 = slept a lot). The feeling of being tired was accompanied by yellowing of the eyes, paleness, general weakness, and irritability. It is therefore possible that some participants may have low steady state hemoglobin that may explain the feeling of being tired. Because the pain intensity ratings were mild and ibuprofen was the pain medication reported, the feeling of being tired was not likely related to narcotic administration. Participants were specifically invited by the SCDFC, a community-based organization. Therefore, the pain and symptoms experiences may be different from a normative sample, and may not be representative of children and adolescents with SCD who have more or less frequent pain episodes at home and/or who were routinely receiving follow-up services in comprehensive medical centers. To our knowledge, the web-based e-Diary was the only one available for children and adolescents with SCD that includes measures of the multiple dimensions of pain (ie, intensity, location, quality descriptors for affective, evaluative, sensory, and temporal dimensions). A unique feature of the web-based e-Diary was that it included items specific to SCD, such as symptoms that may potentially trigger pain episodes, 26, 37 and pain medications that were not typically included in previously reported e-Diaries. 5, 7 Previous studies of e-Diaries utilized the Children's Symptom Inventory, with 35 symptoms. Some of these symptoms were not applicable to SCD, and items that were highly relevant to SCD, such as pain with urination, and pain in the genitals were not included in the Children's Symptom Inventory. 6, 7, 38 Previous studies in SCD have used paper pain diaries that asked participants to report similar questions to the web-based e-Diary used in our study. For example, McClish et al 36 used a paper pain diary in adults in the PiSCES. The PiSCES diary was modeled after the one used in the Multicenter Study of Hydroxyurea. 39 The paper pain diary 34, 39 asked patients to record daily (1) worst sickle cell pain intensity, on a scale from 0 (none) to 9 (unbearable); (2) whether or not they were in a sickle cell crisis; and (3) whether they had gone for an unscheduled physician visit, ED visit, or were hospitalized because of sickle cell pain. Our e-Diary was different in that we used a 10-unit metric as a measure of pain intensity. The 0 to 10 metric was commonly used by clinicians when assessing pain. Von Baeyer and Hicks 30 recommended that all pediatric pain scales have a 10-unit metric so as to decrease confusion from the many differing numerical values. Our e-Diary also included other dimensions of pain (location, evaluative, affective, sensory, temporal quality), and other factors that could affect the overall pain ratings such as fluids, sleep, thoughts/feelings, symptoms, medications, and other strategies used for pain.
The diary used in the PiSCES study 36 also asked adult participants to mark a body chart, indicating where they hurt. However, the analyses were limited to the number of participants marking a specific body area and the number of body areas marked as done in other pain studies, 7, 21, 22 and did not account for change in body surface area. In our web-based e-Diary, not only the number of body location but also the surface area could be marked and was also quantifiable by percentage of body surface area (Fig. 2) . We believed this was important, as our previous data 25 in children and adolescents with SCD showed that although the intensity may not change significantly, the spatial distribution of the pain changed daily (a decrease by 50% to 60%). Participants were able to highlight portions of a body area that were painful; but the segments were preserved from the original paper-based measure. Therefore, the markings may not truly represent the depth and specific markings within a segmented area. However, the electronic percentage calculation of the segmented area represented a proportion from the total body outline and could be reflective of the pain areas in the body. Although pain quality descriptors were selected on separate screens of the e-Diary to describe quality of pain, participants were not able to In contrast to previous studies that utilized a 7-point cartoon-type faces pain scale, 7 our study used a VAS that was anchored by "none" and "worst", with the scale starting at "none". The VAS in the e-Diary was based on word anchors of "none" to "worst pain" that does not display numbers. The VAS allows participants a wider range of responses to rate their current, worst, and least pain, without the use of numbers that limits responses to the number 10. A disadvantage is that cartoon-type faces scale can be used by younger children, whereas the VAS would have to be used by school-aged children who were tested. However, it is very unlikely that younger children than those who participated in the study will be expected to self-monitor pain and symptoms using the smartphone. Similar to our study, McClellan et al 5 used a smartphone to ask participants with SCD to record daily pain using an e-diary. However, it only had a few items to assess the morning and evening pain, followed by questions about sleep quality, functional limitations, and use of the coping skills program. The pain diary was limited to pain intensity, without assessing other dimensions (location on a body outline diagram, quality), other symptoms, or medications and other strategies.
Our study utilized a smartphone device that would allow similar features as PDAs that were previously reported in the literature. [7] [8] [9] Additional features of the smartphones include the ability to make direct phone calls, access resources on the internet, and also send/receive text messages to clinicians as well as peers. The smartphone may potentially facilitate communication in a more timely manner than the typical paper-based measures and allow immediate contact with care providers in ways that were not previously possible. Furthermore, smartphone devices are more commonly used than PDAs. The smartphone allows for the development of webbased applications that overcome the issue of developing phone-specific programs. Because smartphones use finger touch, they do not require a stylus or pen, which may potentially break or be lost.
We did not encounter technical problems, such as not being able to connect to internet, loss of data, or data not transmitting to the server during either of the two pilot studies. However, it is possible that these technical problems may be encountered once the smartphones are used in naturalistic settings (home, school, hospital). The smartphone device may be lost, and power failures and damage to the unit may occur. [6] [7] [8] [9] To minimize loss of data, the e-Diary was designed so that data were immediately transmitted using wireless connection. Therefore, we anticipate that data would not be lost even if the device was lost, or broken afterwards.
We were using the smartphone as part of a wireless pain intervention program in a larger study of children and adolescents with SCD. The program allowed them to selfmonitor their symptoms. The program also allowed a health care provider to track symptoms remotely over time. An algorithm was preprogrammed in such a way that an alert message was sent to the health care provider: (1) immediately for e-diary entries of symptoms requiring immediate attention such as fever, changes in breathing, painful erection, severe pain (rating of Z8 on the on the 0 to 10 VAS); (2) if symptoms were checked in 3 consecutive entries (an equivalent of having unrelieved symptoms for 24 h), for symptoms not requiring immediate attention, but which may be potentially serious; (3) if symptoms were checked in 5 consecutive entries (an equivalent of having the symptoms checked for 48 h), for symptoms not requiring immediate attention, but which may potentially lead to sickle cell-related complications. The health care provider was responding and making appropriate referrals to an ED or hematology clinic when needed. Furthermore, the health care provider offered clinical guidance (individually tailored treatments based on standardized algorithms), as well as promoted patient-care provider communication and patient self-care management in a timely manner. [40] [41] [42] The American Society of Pediatric Hematology/Oncology Sickle Cell Summit recommended optimizing access to care and pain treatments from knowledgeable health care providers, such as hematologists and pain specialists. 43 The web-based e-Diary may improve pain management for children and adolescents with SCD who are at increased risk for undertreatment and disruption in activities of daily living because of pain. 44, 45 The handheld wireless technology, such as the smartphone, may potentially minimize barriers (eg, lack of transportation to comprehensive centers and access to knowledgeable providers) that not only limit access to hospital and clinic-based interventions, but also lead to treatment delays. [3] [4] [5] In conclusion, this study provides support for the usability of smartphones to access a web-based e-Diary for self-monitoring of pain and symptoms in children and adolescents with SCD. Usability testing is a procedure used for evaluating technology using a small sample of users (2 to 3 initially, 4 to 8 to drive a useful iterative cycle) to identify technical performance problems, determine time to complete, ease of use, and incorporate user feedback and comments during development. 46 This study also provided support for the feasibility of using the smartphones in children and adolescents with SCD, who pilot tested the e-Diary using the smartphone by describing the pain and symptoms experienced in the previous 12 hours. Smartphones may be critical to improve communications between individuals with SCD and health care providers, to increase accessibility and acceptability of distance treatment programs, 5, [47] [48] [49] and teach children and adolescents about self-monitoring of pain and symptoms, so that they may be addressed in a timely manner to minimize delay in seeking treatment. The majority of children and adolescents were able to access online information, making smartphones an excellent medium to deliver health promotion and preventive treatment strategies. [47] [48] [49] The e-Diaries were used in children as young as 6 years for measurement of symptoms and behaviors in children with recurrent and chronic pain. [7] [8] [9] 50 We currently used the smartphones to access the web-based e-Diary in the Wireless Pain Intervention Program for at risk youths with SCD. The smartphone may be particularly useful for those children and adolescents with SCD who are more severely affected by the disease and frequently use the health care system. Wireless technology may potentially be a costeffective method for measuring health outcomes, engaging participants in self-monitoring and self-management behavioral interventions, and timely communication between patient and health care providers. A major benefit of wireless technology is the automatic data transfer that may potentially improve frequency and contact between the patient and health care providers, and consequently minimize delay in treatments and health care costs associated with ED visits and hospitalizations. 51, 52 
